Retinoids in the treatment of glioma: A new perspective

Cancer Management and Research

Volumn 4, Issue 1, 2012, Pages 233-241

  Mawson, Anthony R ^a  

^a JACKSON STATE UNIVERSITY   (United States)

Author keywords

Epidemiology; Glioma; Hypervitaminosis A; Pathogenesis; Retinoids

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BETA CAROTENE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA ANTAGONIST; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA AGONIST; RETINOIC ACID RECEPTOR BETA INHIBITOR; RETINOID; RETINOL; RETINOL ESTER; TAMIBAROTENE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN HEMORRHAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; FATTY LIVER; FEVER; GLIOMA; HEPATITIS; HUMAN; HYPOTENSION; KIDNEY FAILURE; LEG EDEMA; LIVER CELL DAMAGE; LUNG CANCER; LUNG INFILTRATE; MONOTHERAPY; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SIGNAL TRANSDUCTION; UPREGULATION; WEIGHT GAIN;

EID: 84930477328     PISSN: None     EISSN: 11791322     Source Type: Journal    
DOI: 10.2147/CMAR.S32449     Document Type: Article

References (63)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492-507.
2. Tabatabai G, Hegi M, Stupp R, Weller M. Clinical implications of molecular neuropathology and biomarkers for malignant glioma. Curr Neurol Neurosci Rep. 2012;12:302-307.
3. Croteau D, Mikkelsen T. Adults with newly diagnosed high-grade gliomas. Curr Treat Options Oncol. 2001;2:507-515.
4. Westphal M, Lamszus K. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci. 2011;12:495-508.
5. National Cancer Institute at the National Institutes of Health. General information about childhood brain stem glioma. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/child-brain-stem-glioma/Patient/page1. Accessed July 4, 2012.
6. Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009;472:323-342.
7. National Cancer Institute at the National Institutes of Health. Brain and central nervous system cancers. Available at: http://www.cancer.gov/aboutnci/servingpeople/snapshots/brain.pdf. Accessed July 4, 2012.
8. National Cancer Institute at the National Institutes of Health. State cancer profiles. Available at: http://statecancerprofiles.cancer.gov/cgi-bin/quickprofiles/profile.pl?28&076. Accessed July 4, 2012.
9. Preston-Martin S, Pogoda JM, Schlehofer B, et al. An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol. 1998;27:579-586.
10. Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control. 1997;8:13-24.
11. Burch JD, Craib KJ, Choi BC, Miller AB, Rish HA, Howe GR. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst. 1987;78:601-609.
12. Wrensch M, Minn Y, Chew T, Bondy M, Berger SM. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-299.
13. Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development: Results from the international adult brain tumour study. Int J Cancer. 1999;82:155-160.
14. Farwell JR, Dohrmann GJ, Flannery JT. Medulloblastoma in childhood: An epidemiological study. J Neurosurg. 1984;61:657-664.
15. Geissler E, Staneczek W. SV40 and human brain tumors. Arch Geschwulstforschung. 1998;58:129-134.
16. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr, Goedert JJ. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA. 1988;279:292-295.
17. Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83:191-201.
18. Lane M, Bailey S. Role of retinoid signaling in the adult brain. Prog Neurobiol. 2005;75:275-293.
19. Theodosiou M, Laudet V, Schubert M. From carrot to clinic: an overview of the retinoic acid signalling pathway. Cell Mol Life Sci. 2010;67:1423-1445.
20. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci. 2007;8:755-765.
21. Wang C, Kane MA, Napoli JL. Multiple retinol and retinal dehydrogenases catalyze all-trans-retinoic acid biosynthesis in astrocytes. J Biol Chem. 2011;286:6542-6553.
22. Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol. 1992;10:839-864.
23. Környei Z, Gócza E, Rühl R, et al. Astroglia-derived retinoic acid is a key factor in glia-induced neurogenesis. FASEB J. 2007;21:2496-2509.
24. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med. 1925;42:753-777.
25. Tang XH, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol. 2011;6:345-364.
26. See SJ, Levin VA, Yung WK, Hess KR, Groves MD. 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro Oncol. 2004;6:253-258.
27. Lu J, Zhang F, Zhao D, et al. ATRA-inhibited proliferation in glioma cells is associated with subcellular redistribution of β-catenin via up-regulation of Axin. J Neurooncol. 2008;87:271-277.
28. van Neerven S, Nemes A, Imholz P, et al. Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J Neuroimmunol. 2010;229:169-179.
29. Matsushita H, Hijioka M, Hisatsune A, Isohama Y, Shudo K, Katsuki H. A retinoic acid receptor agonist Am80 rescues neurons, attenuates inflammatory reactions, and improves behavioral recovery after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab. 2011;31:222-234.
30. Mey J. New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J Neurobiol. 2006;66:757-779.
31. Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008;111:2505-2515.
32. Frankel SR, Eardley A, Heller G, et al. All-trans retinoic acid for acute promyelocytic leukemia. Ann Intern Med. 1994;120:278-286.
33. Su YC, Dunn P, Shih LY, et al. Retinoic acid syndrome in patients following the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Chang Gung Med J. 2009;32:535-542.
34. Bushue N, Wan YJY. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev. 2010;62:1285-1298.
35. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981;290:201-208.
36. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
37. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
38. De Vries N, Van Zandwijk N, Pastorino U. The EUROSCAN study: a progress report. Am J Otolaryngol. 1993;14:62-66.
39. Fritz H, Kennedy D, Fergusson D, et al. Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta-analysis. PLoS One. 2011;6(6):e21107.
40. Pasquali MA, Schnorr CE, Feistauer LB, Gelain DP, Moreira JC. Vitamin A supplementation to pregnant and breastfeeding female rats induces oxidative stress in the neonatal lung. Reprod Toxicol. 2010;30:452-456.
41. Zanotto-Filho A, Schröder F, Moreira JCF. Differential effects of retinol and retinoic acid on cell proliferation: a role for reactive species and redox-dependent mechanisms in retinol supplementation. Free Radical Res. 2008;42:778-788.
42. Mollersen L, Paulsen JE, Olstorn HB, Knutsen HK, Alexander J. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice. Carcinogenesis. 2004;25:149-153.
43. Borras E, Zaragoza R, Morante M, et al. In vivo studies of altered expression patterns of p53 and proliferative control genes in chronic vitamin A deficiency and hypervitaminosis. Eur J Biochem. 2003;270:1493-1501.
44. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-857.
45. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69:1071-1085.
46. Li T, Molteni A, Latkovich P, Castellani W, Baybutt RC. Vitamin A depletion induced by cigarette smoke is associated with the development of emphysema in rats. J Nutr. 2003;133:2629-2634.
47. Dan Z, Popov Y, Patsenker E, et al. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J. 2005;19:845-847.
48. Gouillon Z, Lucas D, Li J, et al. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med. 2000;224:302-308.
49. McCaffery P, Koul O, Smith D, Napoli JL, Chen N, Ullman MD. Ethanol increases retinoic acid production in cerebellar astrocytes and in cerebellum. Brain Res Dev Brain Res. 2004;153:233-241.
50. Kane MA, Folias AE, Wang C, Napoli JL. Ethanol elevates physiological all-trans-retinoic acid levels in select loci through altering retinoid metabolism in multiple loci: a potential mechanism of ethanol toxicity. FASEB J. 2010;24:823-832.
51. Clugston RD, Blaner WS. The adverse effects of alcohol on vitamin A metabolism. Nutrients. 2012;4:356-371.
52. Barua AB, Duitsman PK, Kostic D, Barua M, Olson JA. Reduction of serum retinol levels following a single oral dose of all-trans retinoic acid in humans. Int J Vitam Nutr Res. 1997;67:423-426.
53. Paillaud E, Costa S, Fages C, et al. Retinoic acid increases proliferation rate of GL-15glioma cells, involving activation of STAT-3 transcription factor. J Neurosci Res. 2002;67:670-679.
54. Alvarez S, Germain P, Alvarez R, Rodríguez-Barrios F, Gronemeyer H, de Lera AR. Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor. Int J Biochem Cell Biol. 2007;39:1406-1415.
55. Kleinschmidt-DeMasters BK, Orr EA, Savelieva E, Owens GC, Kruse CA. Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression. J Neurooncol. 1999;41:31-42.
56. Apfel C, Bauer F, Crettaz M, et al. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A. 1992;89:7129-7133.
57. Schupp M, Curtin JC, Kim RJ, Billin AN, Lazar MA. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-γ activity. Mol Pharmacol. 2007;71:1251-1257.
58. Papi A, Rocchi P, Ferreri AM, Guerra F, Orlandi M. Enhanced effects of PPARγ ligands and RAR selective retinoids in combination to inhibit migration and invasiveness in cancer cells. Oncol Rep. 2009;21:1083-1089.
59. Krishnan A, Nair SA, Pillai MR. Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med. 2007;6:532-540.
60. Desai TJ, Chen F, Lü J, et al. Distinct roles for retinoic acid receptors alpha and beta in early lung morphogenesis. Dev Biol. 2006;291:12-24.
61. Agudo M, Yip P, Davies M, et al. A retinoic acid receptor beta agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord. Neurobiol Dis. 2010;37:147-155.
62. Jaeckle KA, Hess KR, Yung WK, et al; North American Brain Tumor Consortium. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol. 2003;21:2305-2311.
63. Warnke PC. A 31-year-old woman with a transformed low grade glioma. JAMA. 2010;303:967-976.